2030年までの欧州医薬品受託販売組織市場予測 - 地域分析 - サービス(商用サービスおよび非商用サービス)、モジュール(シンジケートモジュールおよび専用モジュール)、治療領域(心血管疾患、腫瘍学、代謝性疾患、神経学、整形外科疾患、感染症など)、エンドユーザー(バイオ医薬品会社、製薬会社)

BMIRE00030018 | Pages: 88 | Pharmaceuticals | Apr 2024 | Type: Regional | Status: Published
ヨーロッパの医薬品受託販売組織市場は、2022年の19億890万米ドルから2030年までに34億7497万米ドルに成長すると予想されており、2022年から2030年までに7.8%のCAGRを記録すると推定されています。製品が欧州の医薬品受託販売組織市場を牽引 近年、製薬会社は自社製品の売上を拡大するために革新的な戦略を採用することが増えています。この状況における注目すべき傾向の 1 つは、商業化の取り組みの極めて重要な要素として医薬品受託販売組織 (CSO) への依存度が高まっていることです。これは、市場の複雑さを乗り切るための製薬会社による積極的なアプローチを裏付けています。 CSO と連携することで、これらの企業は専門の営業部隊を活用し、外部の能力を活用して市場浸透を強化し、販売実績を最適化することができます。この協力パラダイムにより、製薬会社は業務を合理化し、研究開発などのコアコンピテンシーに集中できると同時に、CSOのカスタマイズされた専門知識を活用して自社製品の市場での存在感を高めることができます。製薬会社と CSO の間の相乗効果の増大は、リソースの最適化に対する微妙な理解を反映しており、適応性への取り組みと、熾烈な競争が続く製薬業界内で進化するダイナミクスに対する鋭い認識を示しています。この共生関係により、収益の最大化が促進され、持続的な成功には機敏性とターゲットを絞った市場戦略が最も重要な環境に製薬企業を戦略的に位置づけることができます。ヨーロッパの医薬品契約販売組織市場の概要 ヨーロッパの医薬品契約販売組織市場は、ドイツ、英国、フランス、イタリア、スペイン、およびその他のヨーロッパに分割されています。慢性疾患の急増、高齢者人口の増加、満たされていないニーズを満たすためのさまざまな治療用途のための新薬分子の需要の増加により、この地域では医薬品の需要が大幅に増加しています。 550近くの製薬会社がドイツで事業を展開しています。この国の契約販売組織 (CSO) は、大手製薬会社や小規模バイオテクノロジー企業にサービスを提供し、これらの企業が欧州市場で主導的な地位を獲得できるよう支援しています。 Germany Trade & Invest のデータによると、2020 年のドイツの医薬品売上高は 2019 年と比較して 6.7% 増加し、607 億 9,000 万米ドル (495 億ユーロ) に達しました。ドイツおよびその他のヨーロッパ諸国の製薬産業の状況は、生物学的医薬品の開発により、最近大きな変化を遂げています。その結果、生物学的製剤は、その強力な治療可能性により、製薬ビジネスのかなりの部分を占めるようになりました。大企業は現在、低分子薬の開発ではなく、複雑な生物学的化合物の作成に集中しています。 2021年3月、IQVIAはジョンソン・エンド・ジョンソンの子会社であるヤンセン製薬会社の1つであるヤンセン・リサーチ・アンド・ディベロップメントLLCと協力して、ヤンセンの新型コロナウイルス感染症ワクチンの第3相臨床試験を実施した。遠隔医療技術、仮想監視、デジタル患者対話戦術を組み合わせたこの試験では、現場および遠隔地での研究によってサポートされた IQVIA の一連の分散型試験ソリューションが活用されました。 IQVIA は、さまざまなクライアント製品の発売とマーケティングを専門とする世界最大の商用ソリューション組織を擁しており、ヨーロッパのさまざまな国に拠点を置いています。ヨーロッパの医薬品受託販売組織市場の収益と2030年までの予測(百万米ドル) ヨーロッパの医薬品受託販売組織の市場セグメンテーション ヨーロッパの医薬品受託販売組織の市場は、サービス、モジュール、治療領域、エンドユーザー、および国に分割されています。サービスに基づいて、ヨーロッパの医薬品受託販売組織市場は商用サービスと非商用サービスに二分されます。商用サービスセグメントは、2022年の欧州の医薬品受託販売組織市場で大きなシェアを占めました。モジュールに基づいて、欧州の医薬品受託販売組織市場はシンジケートモジュールと専用モジュールに二分されます。シンジケートモジュールセグメントは、2022年のヨーロッパの医薬品受託販売組織市場で大きなシェアを占めました。治療領域に基づいて、ヨーロッパの医薬品受託販売組織市場は、心血管疾患、腫瘍学、代謝障害、神経学、整形外科疾患、感染症、その他。オンコロジー部門は、2022年の欧州医薬品受託販売組織市場で最大のシェアを占めました。欧州の医薬品受託販売組織市場は、エンドユーザーに基づいて、バイオ医薬品会社と製薬会社に二分されます。製薬会社セグメントは、2022年のヨーロッパの医薬品受託販売組織市場で大きなシェアを占めました。国に基づいて、ヨーロッパの医薬品受託販売組織市場は英国、ドイツ、フランス、スペイン、イタリア、およびその他のヨーロッパに分割されています。 2022 年の欧州の医薬品受託販売組織市場はドイツが独占しました。Aenova Holding GmbH、IQVIA Holdings Inc、MaBico SA、Pfizer Inc、および Syneos Health Inc は、欧州の医薬品受託販売組織市場で事業を展開する大手企業です。
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe PEST Analysis

5. Europe Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Integration of Digital Technologies

5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products

5.2 Key Market Restraints

5.2.1 Quality Issues Associated with Outsourcing

5.3 Key Market Opportunities

5.3.1 Rising Use of Telemedicine and Remote Detailing

5.4 Key Future Trends

5.4.1 Expansion in Emerging Markets

5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Europe Market Analysis

6.1 Europe Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview

7.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

7.3 Commercial Services

7.3.1 Overview

7.3.2 Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Commercial Services

7.4.1 Overview

7.4.2 Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview

8.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

8.3 Syndicated Modules

8.3.1 Overview

8.3.2 Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Dedicated Modules

8.4.1 Overview

8.4.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview

9.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

9.3 Cardiovascular Disorders

9.3.1 Overview

9.3.2 Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Metabolic Disorders

9.5.1 Overview

9.5.2 Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Neurology

9.6.1 Overview

9.6.2 Neurology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.7 Orthopaedic Diseases

9.7.1 Overview

9.7.2 Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.8 Infectious Diseases

9.8.1 Overview

9.8.2 Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

10.3 Biopharmaceutical Companies

10.3.1 Overview

10.3.2 Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Pharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 Europe Pharmaceutical Contract Sales Organizations Market, Revenue and Forecast to 2030

11.1.1.1 Europe Pharmaceutical Contract Sales Organizations Market, by Country

11.1.1.2 UK

11.1.1.2.1 UK: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.2 UK: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.2.3 UK: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.2.4 UK: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.2.5 UK: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.3 Germany

11.1.1.3.1 Germany: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.2 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.3.3 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.3.4 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.3.5 Germany: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.4 France

11.1.1.4.1 France: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.4.2 France: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.4.3 France: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.4.4 France: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.4.5 France: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.5 Italy

11.1.1.5.1 Italy: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.5.2 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.5.3 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.5.4 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.5.5 Italy: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.6 Spain

11.1.1.6.1 Spain: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.6.2 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.6.3 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.6.4 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.6.5 Spain: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.7 Rest of Europe

11.1.1.7.1 Rest of Europe: Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.7.2 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.7.3 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.7.4 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.7.5 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview

12.2 Growth Strategies

12.2.1 Overview

13. Company Profiles

13.1 MaBico SA

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 IQVIA Holdings Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Syneos Health Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Aenova Holding GmbH

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Pfizer Inc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

?

List of Tables

Table 1. Europe Pharmaceutical Contract Sales Organizations Market Segmentation

Table 2. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 3. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 4. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 5. UK: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 6. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 7. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 8. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 9. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 10. France: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 11. France: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 12. France: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 13. France: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 15. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 16. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 17. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 18. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 19. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 20. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 21. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 22. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 23. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 24. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 25. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market

Table 27. Glossary of Terms, Europe Pharmaceutical Contract Sales Organizations Market

?

List of Figures

Figure 1. Europe Pharmaceutical Contract Sales Organizations Market Segmentation, By Country

Figure 2. Europe PEST Analysis

Figure 3. Europe Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. Europe Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

Figure 6. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

Figure 7. Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

Figure 10. Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

Figure 13. Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Oncology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Neurology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 21. Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Europe Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 24. Europe Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)

Figure 25. UK: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Germany: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. France: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Italy: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 29. Spain: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 30. Rest of Europe: Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

1. Aenova Holding GmbH

2. IQVIA Holdings Inc

3. MaBico SA

4. Pfizer Inc

5. Syneos Health Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Pharmaceutical Contract Sales Organizations Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440